PDCD1 and neoplasm: Paradoxically, our data suggest that ionizing irradiation may induce multiple resistance mechanisms that could facilitate tumor relapse, e.g. via enhancing CXCL12 and also CD274/CD279 (PD-L1/PD-1) signaling, thus limiting anti-tumor immunity [32, 33].